Bridgefront Capital, LLC Amgen Inc Transaction History

Bridgefront Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $453,937 - $576,781	1,982 New	1,982 $520,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $679,264 - $795,840	-3,200 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $747,456 - $829,248	3,200 New	3,200 $780,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $732,303 - $853,380	-3,300 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $714,054 - $850,311	3,300 New	3,300 $759,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.